首页>
外国专利>
Agents for treatment of glaucomatours retinopathy and optic neuropathy
Agents for treatment of glaucomatours retinopathy and optic neuropathy
展开▼
机译:青光眼视神经病变和视神经病变的治疗剂
展开▼
页面导航
摘要
著录项
相似文献
摘要
Agents that stimulate nuclear translocation of Nrf2 protein and the subsequent increases in gene products that detoxify and elimate cylotoxic metabolites are provided in a method for treating glaucomatous retinopathy or optic neuropathy. The structurally diverse agents that act on the Nrf2/ARE pathway induce the expression of enzymes and proteins that possess chemically versatile cytoprotective properties and are a defense against toxic metabolites and xenobiotics. Agents include certain electrophiles and oxidants such as a Michael Addition acceptor, diphenol, thiocarbamate, quinone, 1,2-dithiole-3-thione, butylated hydroxyanisole, flavonoid, an isothiocyanate, 3,5-di-tert-butyl-4-hydroxytolune, ethoxyquin, a coumarin, combinations thereof, of a pharmacologically active derivative or analog thereof.
展开▼